Cargando…
P706: RESISTANCE TO HYPOMETHYLATING AGENTS (HMA) IN HIGH-RISKMYELODYSPLASTIC SYNDROME (HR-MDS): THE ROLE OF THE ADENOSINEDEAMINASE ACTING ON RNA 1 (ADAR1) ENZYME
Autores principales: | Dimitriou, Despoina, Lamprianidou, Eleftheria, Tasis, Athanasios, Spiropoulos, Theodoros, Kimparidou, Chrysa, Papadakis, Stavros, Liapis, Konstantinos, Papoutselis, Menelaos, Vrachiolias, George, Mitroulis, Ioannis, Kotsianidis, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428684/ http://dx.doi.org/10.1097/01.HS9.0000969728.11589.4c |
Ejemplares similares
-
Common cardiovascular biomarkers can independently predict outcome of patients with Myelodysplastic syndromes
por: Mitroulis, Ioannis, et al.
Publicado: (2023) -
P701: SYSTEMATIC ANALYSIS OF T LYMPHOCYTES IN MYELOID NEOPLASMS
por: Tasis, Athanasios, et al.
Publicado: (2023) -
Blood and platelet transfusion from a donor with presymptomatic Covid-19
por: Liapis, Konstantinos, et al.
Publicado: (2020) -
Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression
por: Kazachenka, Anastasiya, et al.
Publicado: (2019) -
Azacytidine Failure Revisited: an Appraisal Based on Real-Life Data from the MDS Registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS)
por: Kotsianidis, Ioannis, et al.
Publicado: (2019)